Prospects for a mucosally-administered vaccine against Helicobacter pylori

By Svennerholm A.-M.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 347-353

Elsevier

Access to resources Recommend Favorite

The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases

By Gomez-Duarte O.G.   Bumann D.   Meyer T.F.  

Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. : 1667-1673

Elsevier

Access to resources Recommend Favorite

Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy

By Koesling J.   Lucas B.   Develioglou L.   Aebischer T.   Meyer T.F.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 413-420

Elsevier

Access to resources Recommend Favorite

Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy

By Blanchard T.G.   Eisenberg J.C.   Matsumoto Y.  

Vaccine, Vol. 22, Iss. 7, 2004-02 ,pp. : 888-897

Elsevier

Access to resources Recommend Favorite

Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori-catalase

By Miyashita M.   Joh T.   Watanabe K.   Todoroki I.   Seno K.   Ohara H.   Nomura T.   Miyata M.   Kasugai K.   Tochikubo K.   Itoh M.   Nitta M.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2336-2342

Elsevier

Access to resources Recommend Favorite